- Market Capitalization, $K 153,310
- Shares Outstanding, K 33,041
- Annual Sales, $ 7,300 K
- Annual Income, $ -39,610 K
- 60-Month Beta 2.41
- Price/Sales 20.51
- Price/Cash Flow N/A
- Price/Book 2.84
|Period||Period Low||Period High||Performance|
| || |
-1.17 (-20.14%)since 06/10/20
| || |
+0.97 (+26.43%)since 04/09/20
| || |
-6.29 (-57.55%)since 07/10/19
Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, announced the appointment of current board member Yves Ribeill, Ph.D., as Chairman. This appointment coincides with Dr. Andre Choulika's decision...
Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, announced today that its high oleic low linolenic (HOLL) soybean has been deemed a non-regulated article under the "Am I Regulated?" process...
U.S. consumer confidence gained in May and beat the expectations of economists polled by Dow Jones.
Calyxt (CLXT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
--Provides Update on COVID-19 Impact
--Allergen and Gluten-Free, With Zero Grams Trans-Fat Per Serving
Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, will hold a conference call on Thursday, May 7, 2020 at 8:30 a.m. Eastern time to discuss its results for the first quarter ended March 31,...
Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has licensed a new method to help increase plant gene editing efficiency from the University of Minnesota. The method has the potential to...
Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has launched its new website to showcase how Calyxt is harnessing the 'Power and Possibilities of Plants'.
--Expanded Product Pipeline to Nine Crops and 14 Projects Under Development, Compared to Five Crops and Six Projects Under Development One Year Ago